This is a working overview of Stenabolic, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-05-07. Anything still debated is marked as such rather than presented as settled.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Binds REV-ERBα and REV-ERBβ in preclinical models |
| Molecular formula | C20H24ClN3O4S | Reported for the parent compound |
| CAS Registry Number | 1379686-30-2 | Common identifier in chemical databases |
| Appearance | Off-white to pale yellow solid | Typical research chemical solid |
| Solubility | Soluble in DMSO and ethanol; low in water | Class: small organic molecule |
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.
SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
The country's ten largest self-reported ethnic or cultural origins in 2021 were Canadian (accounting for 15.6 percent of the population), followed by English (14.7%), Irish (12.1%), Scottish (12.1%), French (11.0%), German (8.1%), Chinese (4.7%), Italian (4.3%), Indian (3.7%), and Ukrainian (3.5%). Of the 36.3 million people enumerated in 2021, approximately 25.4 million reported being "White", representing 69.8 percent of the population. The Indigenous population representing 5 percent or 1.8 million people, grew by 9.4 percent compared to the non-Indigenous population, which grew by 5.3 percent from 2016 to 2021. One out of every four Canadians or 26.5 percent of the population belonged to a non-White and non-Indigenous visible minority, the largest of which in 2021 were South Asian (2.6 million people; 7.1%), Chinese (1.7 million; 4.7%), Black (1.5 million; 4.3%), Filipinos (960,000 2.6%), Arabs (690,000; 1.9%), Latin Americans (580,000; 1.6%), Southeast Asians (390,000; 1.1%), West Asians (360,000; 1.0%), Koreans (220,000; 0.6%) and Japanese (99,000; 0.3%). Between 2011 and 2016, the visible minority population rose by 18.4 percent. In 1961, about 300,000 people, less than two percent of Canada's population, were members of visible minority groups. The 2021 census indicated that 8.3 million people, or almost one-quarter (23.0%) of the population, reported themselves as being or having been a landed immigrant or permanent resident in Canada—above the 1921 census previous record of 22.3 percent.
Adverse reaction Adverse event Adverse drug reaction Biosecurity Biosecurity in the United States Drug Efficacy Study Implementation Food and Drug Administration Modernization Act of 1997 FDA Food Safety Modernization Act of 2011 FDA Fast Track Development Program (for drugs) Food and Drug Administration Amendments Act of 2007 (e.g. drugs) Food and Drug Administration Safety and Innovation Act of 2012 (GAIN/QIDP etc.) Inverse benefit law Investigational Device Exemption (for use in clinical trials) Kefauver Harris Amendment 1962 – required "proof-of-efficacy" for drugs International:
mycoides because the latter bacterium grows much faster, which translated into quicker experiments. Venter describes it as "the first species.... to have its parents be a computer". The transformed bacterium is dubbed "Synthia" by ETC. A Venter spokesperson has declined to confirm any breakthrough at the time of this writing.
There is evidence that suggests that wind turbines might create sufficient barotrauma (pressure damage) to kill bats. Bats have typical mammalian lungs, which are thought to be more sensitive to sudden air pressure changes than the lungs of birds, making them more liable to fatal rupture. Bats may approach turbines to roost on them, increasing the death rate. Ultrasonic signals may help to deter bats from approaching wind farms, thus reducing deaths. The diagnosis and contribution of barotrauma to bat deaths near wind turbine blades have been disputed by other research comparing dead bats found near wind turbines with bats killed by impact with buildings in areas with no turbines. The effects of climate change on bats are debated; a 2022 literature review concluded that, "Several biological and ecological traits of bats may make them sensitive to climate change, yet there is surprisingly little evidence on how these mammals respond to this anthropogenic environmental pressure." A 2025 study of European species found that bat populations may be shifting their ranges further north. Specifically, range suitability declined markedly in southern Europe while increasing at higher northern latitudes.
Sources: en.wikipedia.org
Loop type, in which the primary coolant is circulated through primary heat exchangers outside the reactor tank (but inside the biological shield due to radioactive 24Na in the primary coolant) Pool type, in which the primary heat exchangers and pumps are immersed in the reactor tank There are only two commercially operating breeder reactors as of 2017: the BN-600 reactor, at 560 MWe, and the BN-800 reactor, at 880 MWe. Both are Russian sodium-cooled reactors. The designs use liquid metal as the primary coolant, to transfer heat from the core to steam used to power the electricity generating turbines. FBRs cooled by liquid metals other than sodium have been built, some early FBRs such as Clementine used mercury, Lead-cooled fast reactor have also been constructed, as well as other experimental reactors using Lead-bismuth eutectic or NaK, a sodium-potassium alloy. Mercury and NaK have the advantage that they are liquids at room temperature, which is convenient for experimental rigs but less important for pilot or full-scale power stations, where their chemical toxicity and cost respectively leave them as less attractive options. The Soviet Union used lead–bismuth coolant in some naval reactors. BREST-OD-300 is a later Russian design that uses lead coolant. Its first concrete was poured in June 2021. The SVBR-100 design specifies lead-bismuth eutectic as its coolant. Three of the proposed generation IV reactor types use a fast-neutron spectrum:
Human diploid cell rabies vaccines (HDCV) Approved HDCVs are grown in the MRC-5 cell line and contains the Pitman-Moore L503 or Flury strain. They are purified by ultrafiltration. HDCVs were first experimentally made by using the WI-38 cell line in 1961. This was a gift to Hilary Koprowski at the Wistar Institute by Leonard Hayflick, an Associate Member, who developed this normal human diploid cell strain. Purified chick embryo cell vaccinee (PCECV) Produced by growing fixed rabies virus strain Flury LEP-25 in primary cultures of chick fibroblasts. Ultracentrifuged. Purified Vero cell rabies vaccine (PVRV) Produced by growing the Wister strain in vero cells, which means the vaccine can be made by growing in a bioreactor vat, making it easier to mass produce. Ultracentrifuged. Brand names include Verorab (Sanofi-Aventis) and Speeda (Liaoning Chengda). Verorab is approved in the Australia European Union. It is also prequalified by the WHO, which means that it is considered appropriate to be used by UN organizations. Primary Hamster Kidney Cell vaccine (PHKCV) Contains the Beijing strain grown in baby hamster kidney cells. Ultracentrifuged. Purified duck embryo vaccine (PDEV) Grown in fertilized duck eggs and ultracentrifuged.
=== Chengdu Uprising === By 1949, it was clear that the communist forces under the People's Liberation Army would triumph in the Chinese Civil War. In January, Liu Wenhui travelled to Nanjing to meet with Chiang Kai-shek and assess the political situation; he concluded that Chiang was losing the war and began preparations for defection. Liu accelerated his plans after the Lanzhou Campaign concluded in August with a communist seizure of the city. He began intensifying contacts with underground communists in Sichuan, including Zhang Zhihe and Peng Dixian, in order to coordinate operations. Chiang had attempted to draw Liu out of Xikang by offering him a position as chairman of the Mongolian and Tibetan Affairs Commission, which was refused by Liu.
=== Burns === The Healing Foundation facilitated the establishment of two research centres dedicated to burns. The first, situated at Frenchay Hospital in Bristol, aimed to develop innovative techniques for burn prevention and enhance clinical care for affected children. The Centre for Children's Burns Research was officially opened in June 2013 by Sophie, Duchess of Edinburgh. Subsequently, another research hub, the Healing Foundation Centre for Burns Research, was inaugurated at Queen Elizabeth Hospital in Birmingham in October 2013. A notable outcome of The Healing Foundation Centre for Children's Burns Research was the SmartWound PREDICT Dressing, developed by scientists at the University of Bath. This dressing changes colour upon detecting bacteria, providing an alternative method for infection detection.
== WHO prequalified products == The World Health Organization Immunization Devices Prequalification (IMD-PQS) programme maintains a list of immunization cold chain equipment that it has prequalified for procurement and use by national immunization programmes of the WHOs Expanded Programme on Immunization (EPI), including refrigerators. IMD-PQS prequalifies products based on rigorous performance specifications that it develops in collaboration with national immunization programmes and in consultation with product manufacturers, to ensure that products address the specific needs of immunization programmes’ operating environments.
Sources: en.wikipedia.org
The Ancient Greek philosopher Empedocles saw water as one of the four classical elements (along with fire, earth, and air), and regarded it as an ylem, or basic substance of the universe. Thales, whom Aristotle portrayed as an astronomer and an engineer, theorized that the earth, which is denser than water, emerged from the water. Thales, a monist, believed further that all things are made from water. Plato believed that the shape of water is an icosahedron – flowing easily compared to the cube-shaped earth. The theory of the four bodily humors associated water with phlegm, as being cold and moist. The classical element of water was also one of the five elements in traditional Chinese philosophy (along with earth, fire, wood, and metal). Some traditional and popular Asian philosophical systems take water as a role-model. James Legge's 1891 translation of the Dao De Jing states, "The highest excellence is like (that of) water. The excellence of water appears in its benefiting all things, and in its occupying, without striving (to the contrary), the low place which all men dislike.
A cohort study indicates dietary intakes of total flavonols – and at least kaempferol- and quercetin-containing foods in specific – may substantially decrease decline in multiple cognitive abilities with older age, showing a difference of "0.4 units per decade" between 5 mg and 15 mg intakes. A paywalled study reports higher percentage of daily energy consumption of ultra-processed foods, such as white bread or instant noodles, was associated with faster cognitive decline in aging. Differences can be as large or larger than a 28% faster rate of global cognitive decline. Pharmaceutical/supplemental intervention-related results Researchers report that the widely used supplements glycine and NAC when combined as "GlyNAC", which previously showed various beneficial effects in humans i.a. in a small trial by the authors, can extend lifespan by 24% in mice when taken at old age. Biomedical gerontologists demonstrate a mechanism of anti-aging senolytics, in particular of Dasatinib plus Quercetin (D+Q) – an increase of α-Klotho as shown in mice, human cells and in a human trial. A study reports that in model animals, treatment with rapamycin – which typically has negative side-effects – for a limited timespan extended lifespan as much as life-long administration started at the same age and that it was most effective during early adulthood.
The two discover that Tender has been running a round-tripping scheme, falsifying profits by overstating the costs of its acquisitions of third-party payment processors in Ghana and bribing officials to help stage publicity photos. Her findings enable Harper to make a public case against Tender at an investor conference, causing its stock to fall 28%. The Tender short is ultimately successful, netting the fund £110 million, with Sweetpea, Harper and Kwabena distributing £2 million amongst themselves. The three later explore an office for their fund.
In December 2022, Bukele tweeted that he believed that the country's 262 municipalities should be reduced to 50. He called it "absurd" ("absurdo") that El Salvador, around 8,100 square miles (21,000 km2) in size, had so many municipalities. Some lawyers and politicians criticized Bukele's proposed reduction as an attempt to consolidate power by gerrymandering. His allies supported the proposal, with some proposing a reduction in the number of Legislative Assembly seats. On 1 June 2023, during a speech commemorating his fourth year in office, Bukele announced that he would present two proposals to the Legislative Assembly. One sought to reduce the number of seats in the assembly from 84 to 60, and the other sought to reduce the number of municipalities from 262 to 44. Bukele justified the legislative reduction by saying that the legislature had 60 seats before the signing of the Chapultepec Peace Accords in 1992 that ended the Salvadoran Civil War, and the accords' only accomplishment was the addition of 24 seats to the legislature. About the municipal-reduction proposal, he stated that the 262 municipalities would retain their cultural identities and be classified as districts. The Legislative Assembly approved the proposal for legislative reductions on 7 June 2023, and approved the proposal for municipal reductions six days later. Both reductions became effective on 1 May 2024.
Sources: en.wikipedia.org
SR9009 is a synthetic small molecule studied as an agonist of the REV-ERB nuclear receptors. It is not an approved medicine, and its effects in humans are not well characterized.
No. It is a synthetic ligand that binds nuclear receptors, not a steroid or peptide hormone. Its activity depends on receptor binding rather than endocrine secretion.
Clinical evidence is limited. Most published data come from cell and animal experiments. Human safety and efficacy remain uncertain.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.